MedTrace Logo

ASF Alport Patient Registry

NCT06526741 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2026-04-14

No results posted yet for this study

Summary

Alport Syndrome Foundation's (ASF's) Alport Patient Registry (the Registry) is open to individuals living with Alport syndrome in the United States (US) and US territories and outlying islands. The Registry welcomes participants of all ages who have a confirmed clinical diagnosis of Alport syndrome. A confirmed diagnosis could be obtained via genetic testing, biopsy, and/or from a medical professional's clinical assessment of the individual's symptoms and/or family history. Participants can have any form and stage of this disease to be eligible for inclusion in the Registry.

Patient participation in the Registry is crucial to helping attract and advance research, understanding understudied aspects of the disease, and informing clinical trials that may lead to Alport syndrome therapies and/or a cure.

The Registry is accessed through a secure, online application. Participants report their own health history in the Registry and are encouraged to update any changes, at most, every three months.

The security of each participant's information is a top priority. Any detail that could identify an individual participant is kept confidential in the Registry and such data are de-identified to protect the participant's privacy. No electronic health records or social security numbers are requested by or connected to the Registry.

A parent or legal guardian may consent to enroll a child/dren Alport patient(s) under the age of 18 years. An additional assent form is used for individuals ages 7-17. At age 18, participants will be required to re-consent as an adult if they choose to continue to participate in the Registry.

Conditions

  • Alport Syndrome
  • Thin Basement Membrane Disease
  • Hereditary Nephritis

Interventions

OTHER

Longitudinal data collection

This is an observational ambispective non-interventional registry collecting longitudinal real-world data only. There is no intervention.

Sponsors & Collaborators

  • Pulse Infoframe Inc

    collaborator INDUSTRY

  • Alport Syndrome Foundation

    lead OTHER

Principal Investigators

  • Makabe Aberle, BS · Alport Syndrome Foundation

  • Bradley Warady, MD · Medical Advisory Committee, Alport Syndrome Foundation

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-24
Primary Completion
2048-08-23
Completion
2048-08-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06526741 on ClinicalTrials.gov